Related Experiment Video
Updated: Apr 15, 2026

Fast Inspection of Quality of Indigo Naturalis by Multiple Light Scattering
Published on: August 18, 2023
Development, validation and comparison of NIR and Raman methods for the identification and assay of poor-quality oral
J K Mbinze1, P-Y Sacré2, A Yemoa3
1University of Liege (ULg), Department of Pharmacy, CIRM, Laboratory of Analytical Chemistry, 1 Avenue de l'Hôpital, B36, B-4000 Liège, Belgium; Laboratoire d'Analyse des Médicaments, Département de Galénique et d'Analyse des Médicaments, Université de Kinshasa, BP 212, Kinshasa XI, Democratic Republic of Congo.
Abstract:
Poor quality antimalarial drugs are one of the public's major health problems in Africa. The depth of this problem may be explained in part by the lack of effective enforcement and the lack of efficient local drug analysis laboratories. To tackle part of this issue, two spectroscopic methods with the ability to detect and to quantify quinine dihydrochloride in children's oral drops formulations were developed and validated. Raman and near infrared (NIR) spectroscopy were selected for the drug analysis due to their low cost, non-destructive and rapid characteristics. Both of the methods developed were successfully validated using the total error approach in the range of 50-150% of the target concentration (20%W/V) within the 10% acceptance limits. Samples collected on the Congolese pharmaceutical market were analyzed by both techniques to detect potentially substandard drugs. After a comparison of the analytical performance of both methods, it has been decided to implement the method based on NIR spectroscopy to perform the routine analysis of quinine oral drop samples in the Quality Control Laboratory of Drugs at the University of Kinshasa (DRC).
More Related Videos
08:31Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
Published on: October 11, 2019
09:24Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017